Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-05-09-Speech-1-150-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-05-09"^^xsd:date2
dcterms:Is Part Of	lp_eu:Free trade agreement with India (debate)2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20110509.20.1-150-000"2
lpv:hasSubsequent	lp_eu:2011-05-09-Speech-1-151-0002
lpv:speaker	lp:Miroslav Mikolášik2
lpv:spokenAs	substitute; DROI (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation for relations with Belarus (2009-09-16--2013-09-25)3 member; REGI (2009-07-16--2012-01-18)3 substitute; ENVI (2009-07-16--2012-01-18)3 member; Delegation for relations with the Korean Peninsula (2009-09-16--2014-06-30)3 unknown; Kresťanskodemokratické hnutie (2009-07-14--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3
lpv:translated text	"Madam President, ladies and gentlemen, the free trade agreement with India is clearly an exciting opportunity, offering tremendous potential for trade with the world’s largest democracy. However, I am rather disappointed that negotiations on the free trade agreement have made only sluggish progress towards the conclusion of a negotiated agreement. In particular, the domain of intellectual property rights requires clear and fair treatment because it is unacceptable, from a human rights perspective, to threaten the fundamental rights of the poorest inhabitants of developing countries, including the right of access to generic medicines and health care. The Commission and the Indian authorities should and must intensify their cooperation on a common definition of counterfeit drugs, an important area which is harmful to patient health, in order that public health is adequately protected."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph